
Blood Glucose Test Strip Market Report and Forecast 2025-2034
Description
The global blood glucose test strip market size was valued at USD 20.59 Billion in 2024, driven by the increasing incidence of diabetes across the globe. The market is expected to grow at a CAGR of 9.40% during the forecast period of 2025-2034, with the values likely to rise to USD 50.56 Billion by 2034.
Blood Glucose Test Strip: Introduction
Blood glucose test strip, also known as diabetes test strip, are used to check sugar levels in the body. These strip can help people identify, monitor and control diabetes.
Blood glucose test strip are coated with a thin layer of gold. This end becomes the strip’s circuit, while the other end has a chemical coating. The latter soaks blood and converts the glucose in your blood to electricity. The electric signal travels from the strip to the meter and shows the blood sugar levels on the meter.
Global Blood Glucose Test Strip Market Analysis
Every year, there are approximately 1.5 million mortalities due to diabetes. While the incidence of diabetes continues to grow, researchers suggest that early detection can lower the burden of deaths associated with the disease. Hence, there has been a significant emphasis on sugar level monitoring leading to high blood glucose test strip market demand.
The prevalence of diabetes type 1 has opened a new horizon for medical research and innovation to control the fatal disease. Owing to the technical and digital advances, smart and non-invasive glucose monitoring devices have emerged in the market. In February 2023, Apple announced that the new Apple Watch will come inbuilt with a feature that allows assessing blood sugar levels without taking a blood sample. It works with the help of a silicon photonics chip to determine the concentration of glucose levels in the body. Similarly, LifePlus, a Silicon Valley startup, is developing a non-invasive wearable wristwatch called LifeLeaf. A sensor that fits inside a smartwatch is also being developed by Afon Technology.
Considering the prevalence of non-invasive and smart technologies, the blood glucose test strip market value may appear to stumble. However, diabetes is a global disease that affects people in both high-income and low-income countries. While people may be able to afford the new technologies in developed countries, the population of low income and developing countries will prefer using blood glucose test strip as an affordable alternative for diabetes diagnosis.
Global Blood Glucose Test Strip Market Segmentation
Blood Glucose Test Strip Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Diabetes affects more than half of the world's population, with the current global prevalence of 6.1%. Consequently, it is the one of top leading reasons for disabilities and deaths worldwide. Type 2 diabetes contributes to 96% of the overall cases. High BMI (body mass index) is one of the key causes, followed by low physical activity, alcohol and tobacco consumption, dietary risks, and environmental risks. Given the current lifestyle, the population is more likely to develop the disease in the future. Therefore, we can expect blood glucose test strip market growth in the future.
Diabetes is particularly evident in population older than 65 years and above. As Europe and Northern America have the highest share of geriatric population, they have held a huge portion of the blood glucose test strip market share in the historic period. However, sub-Saharan Africa, Northern Africa and Western Africa are expected to witness fastest growth in the population of older people in next three decades. Hence, in the future, it has the potential to become a substantial market for blood glucose testing.
Global Blood Glucose Test Strip Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Blood Glucose Test Strip: Introduction
Blood glucose test strip, also known as diabetes test strip, are used to check sugar levels in the body. These strip can help people identify, monitor and control diabetes.
Blood glucose test strip are coated with a thin layer of gold. This end becomes the strip’s circuit, while the other end has a chemical coating. The latter soaks blood and converts the glucose in your blood to electricity. The electric signal travels from the strip to the meter and shows the blood sugar levels on the meter.
Global Blood Glucose Test Strip Market Analysis
Every year, there are approximately 1.5 million mortalities due to diabetes. While the incidence of diabetes continues to grow, researchers suggest that early detection can lower the burden of deaths associated with the disease. Hence, there has been a significant emphasis on sugar level monitoring leading to high blood glucose test strip market demand.
The prevalence of diabetes type 1 has opened a new horizon for medical research and innovation to control the fatal disease. Owing to the technical and digital advances, smart and non-invasive glucose monitoring devices have emerged in the market. In February 2023, Apple announced that the new Apple Watch will come inbuilt with a feature that allows assessing blood sugar levels without taking a blood sample. It works with the help of a silicon photonics chip to determine the concentration of glucose levels in the body. Similarly, LifePlus, a Silicon Valley startup, is developing a non-invasive wearable wristwatch called LifeLeaf. A sensor that fits inside a smartwatch is also being developed by Afon Technology.
Considering the prevalence of non-invasive and smart technologies, the blood glucose test strip market value may appear to stumble. However, diabetes is a global disease that affects people in both high-income and low-income countries. While people may be able to afford the new technologies in developed countries, the population of low income and developing countries will prefer using blood glucose test strip as an affordable alternative for diabetes diagnosis.
Global Blood Glucose Test Strip Market Segmentation
Blood Glucose Test Strip Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Thick Film Electrochemical Films
- Thin Film Electrochemical Films
- Optical Strip
- Glucose Oxidase
- Glucose Dehydrogenase
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Pre-Diabetes
- Others
- Online
- Offline
- Hospitals
- Home Care
- Diagnostic Laboratories
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Diabetes affects more than half of the world's population, with the current global prevalence of 6.1%. Consequently, it is the one of top leading reasons for disabilities and deaths worldwide. Type 2 diabetes contributes to 96% of the overall cases. High BMI (body mass index) is one of the key causes, followed by low physical activity, alcohol and tobacco consumption, dietary risks, and environmental risks. Given the current lifestyle, the population is more likely to develop the disease in the future. Therefore, we can expect blood glucose test strip market growth in the future.
Diabetes is particularly evident in population older than 65 years and above. As Europe and Northern America have the highest share of geriatric population, they have held a huge portion of the blood glucose test strip market share in the historic period. However, sub-Saharan Africa, Northern Africa and Western Africa are expected to witness fastest growth in the population of older people in next three decades. Hence, in the future, it has the potential to become a substantial market for blood glucose testing.
Global Blood Glucose Test Strip Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- F. Hoffmann-La Roche Ltd
- LifeScan IP Holdings, LLC
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG
- Universal Biosensors
- Nipro
- TaiDoc Technology Corporation
- APEX BIOTECHNOLOGY CORP.
- B. Braun Melsungen AG
- Betachek
- Terumo Corporation
- OMRON Corporation
- Bayer AG (Germany)
- GlaxoSmithKline plc
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Blood Glucose Test Strip Market Overview
- 3.1 Global Blood Glucose Test Strip Market Historical Value (2018-2024)
- 3.2 Global Blood Glucose Test Strip Market Forecast Value (2025-2034)
- 4 Global Blood Glucose Test Strip Market Landscape
- 4.1 Global Blood Glucose Test Strip Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Blood Glucose Test Strip Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Blood Glucose Test Strip Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Blood Glucose Test Strip Market Segmentation
- 6.1 Global Blood Glucose Test Strip Market by Type
- 6.1.1 Market Overview
- 6.1.2 Thick Film Electrochemical Films
- 6.1.3 Thin Film Electrochemical Films
- 6.1.4 Optical Strips
- 6.2 Global Blood Glucose Test Strip Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Glucose Oxidase
- 6.2.3 Glucose Dehydrogenase
- 6.3 Global Blood Glucose Test Strip Market by Application
- 6.3.1 Market Overview
- 6.3.2 Type 1 Diabetes
- 6.3.3 Type 2 Diabetes
- 6.3.4 Gestational Diabetes
- 6.3.5 Pre-Diabetes
- 6.3.6 Others
- 6.4 Global Blood Glucose Test Strip Market by Distribution Channel
- 6.4.1 Market Overview
- 6.4.2 Online
- 6.4.3 Offline
- 6.5 Global Blood Glucose Test Strip Market by End User
- 6.5.1 Market Overview
- 6.5.2 Hospitals
- 6.5.3 Home Care
- 6.5.4 Diagnostic Laboratories
- 6.5.5 Others
- 6.6 Global Blood Glucose Test Strip Market by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Blood Glucose Test Strip Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Blood Glucose Test Strip Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Blood Glucose Test Strip Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Blood Glucose Test Strip Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Blood Glucose Test Strip Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Abbott
- 16.1.1 Financial Analysis
- 16.1.2 Product Portfolio
- 16.1.3 Demographic Reach and Achievements
- 16.1.4 Mergers and Acquisitions
- 16.1.5 Certifications
- 16.2 F. Hoffmann-La Roche Ltd
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 LifeScan IP Holdings, LLC
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 i-SENS, Inc.
- 16.4.1 Financial Analysis
- 16.4.2 Financial Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Ascensia Diabetes Care Holdings AG
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Universal Biosensors
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Nipro
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 TaiDoc Technology Corporation
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 APEX BIOTECHNOLOGY CORP.
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 B. Braun Melsungen AG
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 16.11 Betachek
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Mergers and Acquisitions
- 16.11.5 Certifications
- 16.12 Terumo Corporation
- 16.12.1 Financial Analysis
- 16.12.2 Product Portfolio
- 16.12.3 Demographic Reach and Achievements
- 16.12.4 Mergers and Acquisitions
- 16.12.5 Certifications
- 16.13 OMRON Corporation
- 16.13.1 Financial Analysis
- 16.13.2 Product Portfolio
- 16.13.3 Demographic Reach and Achievements
- 16.13.4 Mergers and Acquisitions
- 16.13.5 Certifications
- 16.14 Bayer AG (Germany)
- 16.14.1 Financial Analysis
- 16.14.2 Product Portfolio
- 16.14.3 Demographic Reach and Achievements
- 16.14.4 Mergers and Acquisitions
- 16.14.5 Certifications
- 16.15 GlaxoSmithKline plc
- 16.15.1 Financial Analysis
- 16.15.2 Product Portfolio
- 16.15.3 Demographic Reach and Achievements
- 16.15.4 Mergers and Acquisitions
- 16.15.5 Certifications
- 17 Global Blood Glucose Test Strip Market - Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.